NDC properties for "Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Topical Gel" (RxCUI 209970)
About this data
The tables show NDC propoerties for Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Topical Gel with the RxCUI 209970
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Topical Gel (RxCUI 209970)
| MMSL_CODE | BD4038 |
|---|---|
| RxCUI | 209970 |
| SPL_SET_ID | 9777acbb-8166-4734-9932-dc66b05bfcb5 |
| Prescribable Synonym | Cetacaine 14 % / 2 % / 2 % Topical Gel |
| RXNAV_STR | Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Topical Gel |
| RxNorm Name | benzocaine 0.14 MG/MG / butamben 0.02 MG/MG / tetracaine 0.02 MG/MG Topical Gel [Cetacaine] |
| RxNorm Synonym | Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Topical Gel |
| Related queries | Interactions (for RxCUI 209970) |
NDC Properties
NDC Item 10223021501
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 10223021501 |
| Related queries | Properties for NDC 9 |
NDC Item 10223021703
| NDC 9 | 10223-0217 |
|---|---|
| NDC 10 | 10223-0217-3 |
| NDC Item | 10223021703 |
| Packaging | 1 JAR in 1 BOX (10223-0217-3) / 32 g in 1 JAR |
| FDA SPL set id | 614129 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0217 |
NDC Item 10223022101
| NDC 9 | 10223-0221 |
|---|---|
| NDC 10 | 10223-0221-1 |
| NDC Item | 10223022101 |
| Packaging | 1 JAR in 1 BOX (10223-0221-1) / 32 g in 1 JAR |
| FDA SPL set id | 614129 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0221 |
NDC Item 10223021501
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 10223021501 |
| Related queries | Properties for NDC 9 |
NDC Item 10223021703
| NDC 9 | 10223-0217 |
|---|---|
| NDC 10 | 10223-0217-3 |
| NDC Item | 10223021703 |
| Packaging | 1 JAR in 1 BOX (10223-0217-3) / 32 g in 1 JAR |
| FDA SPL set id | 614129 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0217 |
NDC Item 10223022101
| NDC 9 | 10223-0221 |
|---|---|
| NDC 10 | 10223-0221-1 |
| NDC Item | 10223022101 |
| Packaging | 1 JAR in 1 BOX (10223-0221-1) / 32 g in 1 JAR |
| FDA SPL set id | 614129 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0221 |
NDC Item 10223021501
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 10223021501 |
| Related queries | Properties for NDC 9 |
NDC Item 10223021703
| NDC 9 | 10223-0217 |
|---|---|
| NDC 10 | 10223-0217-3 |
| NDC Item | 10223021703 |
| Packaging | 1 JAR in 1 BOX (10223-0217-3) / 32 g in 1 JAR |
| FDA SPL set id | 614129 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0217 |
NDC Item 10223022101
| NDC 9 | 10223-0221 |
|---|---|
| NDC 10 | 10223-0221-1 |
| NDC Item | 10223022101 |
| Packaging | 1 JAR in 1 BOX (10223-0221-1) / 32 g in 1 JAR |
| FDA SPL set id | 614129 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0221 |